RAMM Pharma (XCNQ:RAMM) Scaled Net Operating Assets: 0.43 (As of Jan. 2026)


What is RAMM Pharma Scaled Net Operating Assets?

RAMM Pharma XCNQ:RAMM Scaled Net Operating Assets is 0.43 as of Jan. 2026. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

RAMM Pharma's operating assets for the quarter that ended in Jan. 2026 was C$7.47 Mil. RAMM Pharma's operating liabilities for the quarter that ended in Jan. 2026 was C$3.50 Mil. RAMM Pharma's Total Assets for the quarter that ended in Oct. 2025 was C$9.27 Mil. Therefore, RAMM Pharma's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2026 was 0.43.

RAMM Pharma Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RAMM Pharma Scaled Net Operating Assets Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Scaled Net Operating Assets
Get a 7-Day Free Trial 1.06 0.44 0.63 0.40 0.30

RAMM Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.77 0.77 0.33 0.43

XCNQ:RAMM vs ZTS, UTHR: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RAMM Pharma Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's Scaled Net Operating Assets falls into.


RAMM Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

RAMM Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Oct. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Oct. 2025 )
=(Operating Assets (A: Oct. 2025 )-Operating Liabilities (A: Oct. 2025 ))/Total Assets (A: Oct. 2024 )
=(8.466-3.492)/16.749
=0.30

where

Operating Assets(A: Oct. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=9.27 - 0.804
=8.466

Operating Liabilities(A: Oct. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.572 - 0.011 - 0.069
=3.492

RAMM Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jan. 2026 )
=(Operating Assets (Q: Jan. 2026 )-Operating Liabilities (Q: Jan. 2026 ))/Total Assets (Q: Oct. 2025 )
=(7.465-3.497)/9.27
=0.43

where

Operating Assets(Q: Jan. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=8.45 - 0.985
=7.465

Operating Liabilities(Q: Jan. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.558 - 0 - 0.061
=3.497

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.43 mean?
RAMM Pharma (XCNQ:RAMM) has a Scaled Net Operating Assets of 0.43 as of Jan. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on RAMM Pharma and its competitors.
Is RAMM Pharma's Scaled Net Operating Assets too high?
RAMM Pharma's current Scaled Net Operating Assets is 0.43.
How does RAMM Pharma's Scaled Net Operating Assets compare to ZTS and UTHR?
RAMM Pharma's Scaled Net Operating Assets of 0.43 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on RAMM Pharma and its competitors. RAMM Pharma's current Scaled Net Operating Assets is 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RAMM Pharma stock overvalued right now?
Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current Scaled Net Operating Assets is 0.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current Scaled Net Operating Assets is 0.43 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.